What is Wave Life Sciences's D&A?

Wave Life Sciences (WVE) reported D&A of $841K in Q1 2026.

How has Wave Life Sciences's D&A changed year-over-year?

Wave Life Sciences's D&A decreased by 3.9% year-over-year, from $875K to $841K.

What is the long-term trend for Wave Life Sciences's D&A?

Over 4 years (2021 to 2025), Wave Life Sciences's D&A has grown at a -17.7% compound annual growth rate (CAGR), from $7.48M to $3.44M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Wave Life Sciences WVE D&A

D&A at other companies

Eli LillyLLY

$509M+9.9%

Sarepta Therapeutics, Inc.SRPT

$10.59M+6.2%

Ionis PharmaceuticalsIONS

$3.3M+48.2%

Madrigal Pharmaceuticals, Inc.MDGL

$386K+1.8%

ALN

Alnylam PharmaceuticalsALNY

$13.55M-5.9%

Beam TherapeuticsBEAM

$5.61M+1.4%

Other financials

Income statement

See full

Revenue$38.2M+317%

Operating income-$31.3M+37.2%

Net income-$26.1M+44.4%

EPS (diluted)-$0.13+55.2%

Balance sheet

See full

Cash & equivalents$544.6M+124%

Total debt$15.7M-33.4%

Total equity$511.7M+198%

Total assets$583.5M+102%

Cash flow

See full

Operating cash flow-$59.6M+5.5%

CapEx$438.0K+165%

Free cash flow-$60.0M+5.1%

Valuation

See full

Market cap$1.14B+13.0%

Enterprise value$615.92M-22.3%

P/S15.1×-12.2×

Profitability

See full

Operating margin-75.7%-33.6pp

Net margin-66.5%-29.9pp

FCF margin-27.2%-12.6pp

Returns & leverage

See full

Return on equity-53.7%—

Debt / equity0×-0.1×

Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Wave Life Sciences's D&A?: Wave Life Sciences (WVE) reported D&A of $841K in Q1 2026.
How has Wave Life Sciences's D&A changed year-over-year?: Wave Life Sciences's D&A decreased by 3.9% year-over-year, from $875K to $841K.
What is the long-term trend for Wave Life Sciences's D&A?: Over 4 years (2021 to 2025), Wave Life Sciences's D&A has grown at a -17.7% compound annual growth rate (CAGR), from $7.48M to $3.44M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.